Dr. Anthony Rowedder

Rajat Garg is an Interventional Cardiologist and a Cardiologist in Leesburg, Virginia. Dr. Garg is rated as an Advanced provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Carotid Artery Disease, Arterial Embolism, Apoplexy, Endoscopy, and Colonoscopy. Dr. Garg is currently accepting new patients.

Dr. Jeffrey C. Trost is an associate professor of medicine at the Johns Hopkins School of Medicine as well as director of the Cardiac Catheterization Laboratory at Johns Hopkins Bayview Medical Center. His research there focuses on cardiac disease and cardiovascular medicine. He is also currently deputy director of clinical activities at Johns Hopkins Bayview Medical Center. Dr. Trost earned his undergraduate degree at Princeton University and medical degree at the University of Pennsylvania School of Medicine. He completed a residency at the University of Texas Southwestern School of Medicine where he was chief resident from 1999-2000. He was an assistant professor of internal medicine at the University of Texas Southwestern School of Medicine and an interventional cardiovascular fellow at Brown University before joining the Johns Hopkins faculty in 2005. Dr. Trost was most recently recognized with the 2016 Hopkins Medicine Clinical Recognition Award for Quality and Safety and the 2016 Hopkins Cardiology Fellows’ Teaching Award. Dr. Trost is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Coronary Artery Bypass Graft (CABG), and Heart Bypass Surgery.

Dr. Chao-Wei Hwang is an interventional cardiologist and Assistant Professor of Medicine at Johns Hopkins. Dr. Hwang received doctoral and medical training at Harvard Medical School. He completed residency in Internal Medicine at Brigham and Women's Hospital, and Cardiology and Interventional Cardiology fellowships at The Johns Hopkins Hospital. Dr. Hwang joined the Division of Cardiology as faculty in 2011. He spent a year at Virtua Health System in New Jersey as systemwide Director of Interventional Cardiology, and is now Director of the Johns Hopkins Interventional Cardiology Program at Frederick Health Hospital (FHH) and Co-Medical Director of the FHH Cardiac Catheterization Lab. Dr. Hwang is an expert interventional cardiologist specializing in complex coronary interventions, management of acute coronary syndromes and advanced coronary artery disease. He has specialized expertise in PCI of chronic total occlusions (CTO). Dr. Hwang has been involved in a number of device and coronary clinical trials, and his broad areas of research interests include developing and optimizing devices for the treatment of coronary artery disease. Dr. Hwang has published extensively in stent-based drug delivery systems and local delivery systems for cell-based therapies to the heart. Dr. Hwang is rated as a Distinguished provider by MediFind in the treatment of Arterial Embolism. His top areas of expertise are Heart Attack, Apoplexy, Arterial Embolism, Angioplasty, and Percutaneous Coronary Intervention (PCI).